Construction of a ceRNA immunoregulatory network related to the development of vascular dementia through a weighted gene coexpression network analysis
Hongshuo Shi,Fengshan Sun,Tiantian Yang,Min Peng,Min Wang,Yiwen Zhang,Yao Wang,Chengda Dong,Zhaojun Yan,Guomin Si,Wenbo Wang,Yujie Li
DOI: https://doi.org/10.21037/atm-21-1717
IF: 3.616
2021-05-01
Annals of Translational Medicine
Abstract:BACKGROUND: To date, vascular dementia (VaD) lacks effective treatment in clinical practice. There is also growing evidence that VaD may be closely related to the immune response. The development of high-throughput technology, and the recently discovered group of new mediators called competitive endogenous RNAs (ceRNA), provides a unique opportunity to study the immunomodulation of VaD.METHODS: In this study, we used gene expression profiles in the Gene Expression Omnibus (GEO) database to obtain immune-related gene coexpression modules through a weighted gene coexpression network analysis (WGCNA) and gene enrichment analysis. We extracted and merged long non-coding RNA (lncRNA) and microRNA (miRNA) expressions from the GEO database and mapped them with related databases. Subsequently, we used Cytoscape to construct a lncRNA-miRNA-mRNA network, and then we performed an enrichment analysis on the mRNAs in the network to determine their regulatory function. Subsequently, we used an ImmuCellAI immune infiltration analysis and constructed a ceRNA sub-network of related immune cells. Finally, we conducted a gene set enrichment analysis (GSEA) to determine the potential regulatory pathways of the key factors.RESULTS: As a result, we identified the blue module as the key module of immunity and constructed the related CeRNA network. Immune infiltration analysis showed that natural killer T (NKT) cells may be the key immune cells of VaD. Using a Pearson correlation analysis, we identified that <i>B4GALT1</i>, <i>PPP1R3B</i>, <i>MICB</i>, <i>HHAT</i>, <i>DSC2</i>, <i>DNA2</i>, <i>SCARA3</i>, and <i>lncRNA NEAT1</i> may be the key factors of VaD. Our subsequent GSEA analysis showed that <i>lncRNA NEAT1</i> may be regulated by NK cells and toll-like receptors.CONCLUSIONS: Our research provides new therapeutic targets for vascular dementia from the immunological perspective for the first time, including <i>B4GALT1</i>, <i>PPP1R3B</i>, <i>MICB</i>, <i>HHAT</i>, <i>DSC2</i>, <i>DNA2</i>, <i>SCARA3</i>, and <i>lncRNA NEAT1</i>, and our research hopes to provide new treatment options for VaD.
oncology,medicine, research & experimental